Second vote and conclusions

Date 08 October 2016
Event ESMO 2016 Congress
Session The current way to measure PDL-1 biomarkers will not stand the test of time
Topics Immunotherapy
Therapy
Presenter Thomas Powles
Authors T. Powles
  • Oncology, 07836 - Albany/US